CoChat

Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling

Open access
Heinemann, Anja, Cullinane, Carleen, De Paoli-Iseppi, Ricardo, Wilmott, James S., Gunatilake, Dilini, Madore, Jason, Strbenac, Dario, Yang, Jean Y., Gowrishankar, Kavitha, Tiffen, Jessamy C., Prinjha, Rab K., Smithers, Nicholas, McArthur, Grant A., Hersey, Peter, Gallagher, Stuart J. · 2015 · Oncotarget
Cited by 82

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

// Anja Heinemann 1, 2, 3 , Carleen Cullinane 4 , Ricardo De Paoli-Iseppi 2, 5 , James S. Wilmott 2, 5 , Dilini Gunatilake 1, 2, 3 , Jason Madore 2, 5 , Dario Strbenac 6 , Jean Y. Yang 6 , Kavitha Gowrishankar 1, 2 , Jessamy C. Tiffen 1, 2, 3 , Rab K. Prinjha 7 , Nicholas Smithers 7 , Grant A. McArthur 4 , Peter Hersey 1, 2, 3 , Stuart J. Gallagher 1, 2, 3 1 Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, St Leonards NSW, Australia 2 Melanoma Institute of Australia, North Sydney, NSW, Australia 3 Melanoma Immunology and Oncology Group, Centenary Institute, University of Sydney, Camperdown, NSW, Australia 4 Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia 5 Sydney Medical School, University of Sydney, Sydney, NSW, Australia 6 School of Mathematics and Statistics, University of Sydney, Sydney NSW, Australia 7 Epinova Discovery Performance Unit, GlaxoSmithKline, Stevenage, United Kingdom Correspondence to: Stuart J. Gallagher, e-mail: stuart.gallagher@sydney.edu.au Keywords: panobinostat, I-BET151, melanoma, bromodomain, epigenetic Received: February 17, 2015 Accepted: May 23, 2015 Published: June 05, 2015 ABSTRACT Histone acetylation marks have an important role in controlling gene expression and are removed by histone deacetylases (HDACs). These marks are read by bromodomain and extra-terminal (BET) proteins and novel inhibitiors of these proteins are currently in clinical development. Inhibitors of HDAC and BET proteins have individually been shown to cause apoptosis and reduce growth of melanoma cells. Here we show that combining the HDAC inhibitor LBH589 and BET inhibitor I-BET151 synergistically induce apoptosis of melanoma cells but not of melanocytes. Induction of apoptosis proceeded through the mitochondrial pathway, was caspase dependent and involved upregulation of the BH3 pro-apoptotic protein BIM. Analysis of signal pathways in melanoma cell lines resistant to BRAF inhibitors revealed that treatment with the combination strongly downregulated anti-apoptotic proteins and proteins in the AKT and Hippo/YAP signaling pathways. Xenograft studies showed that the combination of inhibitors was more effective than single drug treatment and confirmed upregulation of BIM and downregulation of XIAP as seen in vitro . These results support the combination of these two classes of epigenetic regulators in treatment of melanoma including those resistant to BRAF inhibitors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.4242

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 82

Metadata

Authors
Heinemann, A., Cullinane, C., De Paoli-Iseppi, R., Wilmott, J. S., Gunatilake, D., Madore, J., Strbenac, D., Yang, J. Y., Gowrishankar, K., Tiffen, J. C., Prinjha, R. K., Smithers, N., McArthur, G. A., Hersey, P., & Gallagher, S. J.
Venue
Oncotarget
Published
2015-06-05
Volume
6
Issue
25
Pages
21507-21521
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2168950900
Cited by
82
References
9
FWCI
3.73
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling. https://app.cochat.ai/papers/10.18632/oncotarget.4242
The paper
Heinemann, A., Cullinane, C., De Paoli-Iseppi, R., Wilmott, J. S., Gunatilake, D., Madore, J., Strbenac, D., Yang, J. Y., Gowrishankar, K., Tiffen, J. C., Prinjha, R. K., Smithers, N., McArthur, G. A., Hersey, P., & Gallagher, S. J. (2015). Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling. Oncotarget. https://doi.org/10.18632/oncotarget.4242

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.